Ron Bone is a consultant in the area of Pharmaceutical Traceability and is currently focusing on the implementation of the U.S. 2013 Drug Quality and Security Act. Ron retired from McKesson Corporation where he held the position of Senior Vice President, Distribution Support. His responsibilities included Regulatory Affairs and leading McKesson's product security initiatives through the use of electronic track and trace.
Ron spent 41 years with McKesson Corporation in various operations, sales and financial management positions. He was a member of the of the GS1 Process Oversight Committee, a member of the Leadership Teams of GS1 Global Healthcare and GS1 US Healthcare, and was a member of the Industry Relations Council for the Healthcare Distribution Management Association (HDMA). In 2008, Bone testified before the U.S. House of Representatives, Energy and Commerce Committee as an industry expert on anti-counterfeiting. In 2007, he was the recipient of HDMA’s Nexus Award, which is the industry’s highest honor recognizing leadership, exemplary service and professional excellence.
Ron received his BS and MBA degrees from San Jose State University.
Jeff Denton is currently Senior Director, IT Global Secure Supply Chain at AmerisourceBergen. With over 30 years of experience in the wholesale distribution business, Jeff has held positions of increasing responsibility in finance, procurement, contracts and chargebacks as well as Information Technology.
Over the last 13 years, Jeff has been very involved in a variety of aspects around the supply chain security initiative. In addition, he has participated in numerous standards-activities within HDA and GS1-US/Global.
His current responsibilities include Enterprise IT solutions for AmerisourceBergen’s Global Secure Supply Chain program. Jeff serves at the IT lead and is the key liaison across all of the various business units – aligning implementation with standardization.
Josh Dritz has nearly 25 years of broad supply chain experience across both planning and execution domains. He is currently the Director of Operations Technology and leads a team that has responsibility for providing guidance and adherence to FDA legislative mandates, distribution technology assessments and adoption, and supply chain network strategy. Prior to this role, Josh held various leadership positions in Supply Chain Execution, Inventory Optimization, and led large IT initiatives in the supply chain space. Outside of Cardinal Health, Josh worked in ecommerce and Supply Chain at Whirlpool Corporation and started his career at Arthur Andersen Business Consulting. He has a BS in Decision Sciences from Miami University and an MBA from The Ohio State University.
Anita T. Ducca is HDA’s Senior Vice President of Regulatory Affairs. She serves as the chief liaison and advocate on behalf of HDA with federal regulatory agencies, including FDA and DEA. She has been with the organization since 2002.
Prior to joining HDA, Ms. Ducca was the Director of Regulatory Affairs for the American Red Cross Biomedical Services (ARC), where she was responsible for internal and external regulatory, compliance and health and safety. Anita also served in a regulatory advocacy capacity for the American Petroleum Institute. Earlier, she has also served on the staff of several federal regulatory agencies, including the Food and Drug Administration, the Office of Management and Budget and the Environmental Protection Agency.
Ducca has a BA in Mathematics from Boston College and a MS in Biostatistics from Georgetown University.
Jeff has been involved in software development for the manufacturing and healthcare industries for 32 years. He joined Cardinal Health in 1997, supporting their pharmaceutical distribution business, and over the last eight years has been managing software solutions development for regulatory-related needs. He began his serialization involvement in 2008 to lead serialization and track-and-trace solution development for California and federal regulations.
Jeff is an active participant in GS1 and HDMA. He is a graduate of Le Moyne College in Syracuse, N.Y., where he received his BS in Computer Science.
Justine Freisleben is Senior Director of Industry Relations at the Healthcare Distribution Alliance (HDA). In this role she is responsible for the development and coordination of strategies, initiatives and projects to help healthcare distributors understand and use standards, emerging technologies and best practices to increase their efficiency and productivity in the movement of information and products throughout the healthcare supply chain. Additionally, she guides development of voluntary industry guidelines for implementing and maintaining technical standards related to product identification and electronic commerce ,and represents HDA on key work groups, particularly related to the development of standards and processes to support implementation of traceability.
Prior to this role she worked for a chemical trade association focusing on international trade advocacy and international regulatory compliance.
Justine holds a BA in government from Franklin and Marshall College and a MA/MBA from American University.
Perry L. Fri is HDA’s Executive Vice President of Industry Relations, Membership & Education and Chief Operating Officer of the HDA Research Foundation. At HDA, Fri is responsible for the direction, supervision and development of industry initiatives that facilitate improved business processes and operational efficiencies in the healthcare supply chain. Fri currently serves on the Board of Directors for Healthcare Ready, a 501(c)(3) organization established to help public and private sector stakeholders across the pharmaceutical supply chain prepare for (and maintain operations during) disasters.
Fri most recently served as Vice President of Industry Relations and Program Development for the Health Industry Distributors Association (HIDA). Prior to joining HIDA, Fri was a consultant for The Hale Group. He also was Vice President of Industry Alliances for Instill Corporation, and was the Director of Supply Chain Management for NWDA (now HDA). He holds a BA in History from the University of Maryland.
Elizabeth A. Gallenagh, Esq., is the Senior Vice President, Government Affairs and General Counsel for HDA. She is responsible for overseeing federal and state advocacy on behalf of HDA member companies and is the organization’s chief in-house attorney. Additionally, she serves as HDA’s primary expert on prescription drug traceability, distributor licensure and tax issues.
Since joining HDA in 2003, Ms. Gallenagh led the Alliance's industry-wide efforts to replace a 50-state patchwork of pedigree laws with one national traceability solution, which became a reality through the enactment of Title II of the Drug Quality and Security Act in November 2013. In 2014, she was honored by the industry with the Distribution Management Award for Industry Leadership, which honors an individual who has exhibited the highest standards of honesty and integrity, working to enhance industry relations and knowledge, as well as supply chain efficiency and security.
Gallenagh holds a JD from the George Mason University School of Law and a BA from The George Washington University.
Aaron Graham is the Executive Director of Brand Safety & Security for Boehringer-Ingelheim Pharmaceuticals. Prior to his current assignment, he served in similar senior security roles with global responsibility at Pfizer, Apple and Purdue Pharma. Before transitioning to industry, Aaron began his federal law enforcement career as a Special Agent for the U.S. Drug Enforcement Administration (DEA), where he conducted international undercover investigations and served on the S.W.A.T. team. He subsequently served as a senior special agent and team leader for the FDA Office of Criminal Investigations, where he directed undercover investigations targeting pharmaceutical drug trafficking organizations.
Aaron has briefed members of Federal and State legislative committees regarding the need for enhanced supply chain security regulations; presented global threat analysis and actionable intelligence regarding illicit internet pharmacies to Interpol; testified in U.S. and foreign criminal trials; appeared as an industry expert on NBC Dateline – "Bitter Pills," National Geographic’s documentary, "Illicit: The Dark Trade," ABC World News Tonight, CNN, NPR, Business Week On-Line and in The Wall Street Journal, USA Today, The New York Times, The Washington Post, The Boston Globe, CIO Magazine and Pharmaceutical Executive Magazine, among other newspapers and industry trade publications.
Aaron has been honored to receive recognition and awards from various law enforcement agencies and private sector organizations. In March 2005, FBI LEEDA presented Aaron with their first-ever Innovator Award and acknowledged his leadership and exceptional contributions to the law enforcement community. In 2006, the American Police Hall of Fame presented Aaron with the "Presidents National Medal of Patriotism." In March 2016, Aaron received PhRMA’s "We Work for Health Champions Award."
Katrina Harper has more than 18 years of healthcare experience in several clinical and leadership roles. Currently, as Sr. Clinical Manager at Vizient, she provides pharmaceutical/clinical expertise for her internal team and Vizient Members. Katrina serves as a clinical resource with a primary portfolio focus on pharmaceuticals, but including products in other clinical areas.
Prior to joining Vizient, Katrina was a Pharmacy Manager for a community pharmacy chain, Director of Pharmacy of a cardiovascular specialty hospital, and Medication Safety Officer for a safety-net academic county hospital. She has served as chairperson and adjunct faculty for the ASHP accredited Pharmacy Technology program at a community college. Katrina is also a recipient of the Texas Society of Health-Systems Pharmacist’s Larry C. Nesmith Pharmacist Recognition Award.
Katrina holds a Doctorate of Pharmacy degree from Xavier University of Louisiana College of Pharmacy and a Master’s degree in Business Administration from The University of Texas at Arlington College of Business Administration. She is also a Board Certified Pharmacotherapy Specialist and holds numerous other certifications.